Advertisement

Topics

Latest "OXYGEN" News Stories

00:54 EDT 16th August 2018 | BioPortfolio

Here are the most relevant search results for "OXYGEN" found in our extensive news archives from over 250 global news sources.

More Information about OXYGEN on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about OXYGEN for you to read. Along with our medical data and news we also list OXYGEN Clinical Trials, which are updated daily. BioPortfolio also has a large database of OXYGEN Companies for you to search.

Showing "OXYGEN" News Articles 1–25 of 467

Wednesday 15th August 2018

Teijin Pharma Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryTeijin Pharma Ltd Teijin Pharma, a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. Teijin Pharma business operations include research and development activities, manufactur...


Imara Announces Appointment of Kevin B. Johnson, Ph.D., MBA, as Senior Vice President of Regulatory and Quality

Imara Inc., a clinical stage biopharmaceutical company, today announced that Kevin B. Johnson, Ph.D., MBA, has been appointed Senior Vice President of Regulatory and Quality. Dr. Johnson joins the company from Sucampo Pharmaceuticals and Vtesse, Inc. where he served as Vice President, Global Head of Regulatory and Quality, and Vice President, Global Regula...

Brain Imaging Study Demonstrates Digital Psychiatric Therapy “Re-Wires” the Brain, Resulting in Improved Attention in Children with ADHD

Study in Translational Psychiatry suggests promise of durable non-pharmacologic treatment ATENTIV, LLC, pioneers in digital therapies for Attention Deficit/Hyperactivity Disorder (ADHD) and other cognitive disorders, today announced the publication of a recently completed brain imaging study using the ATENTIVmynd™ Technology platform. T...


In the Wake of the Opioid Epidemic, Multi Radiance Medical Introduces the Next Generation of Non-Invasive, Drug-Free Pain Relief

Drugs and prescription opioids have reached epidemic status in the United States, killing more Americans than car accidents. More and more, patients and clinicians are becoming aware of the need for more effective, less harmful alternatives; enter the laser. CLEVELAND (PRWEB) August 15, 2018 The awful reality is that drugs and prescription opioids have reached epidemic status in the United State...

Children’s Hospitals: Investing in the Health of Our Communities

SOURCE: Alliance Data DESCRIPTION:Sharing our time, talent and financial resources with our neighbors is one of our greatest responsibilities as a profitable company – and we’ve seen how our contributions can improve lives and strengthen communities. “On my son Charlie’s fifth day of life, he was at a routine pediatrician checkup, when we realized he was losing oxygen and his body temperat...

Tuesday 14th August 2018

Profusa raises $45m in Series C financing

Profusa intends to use the proceeds to commercialize its first product, Profusa Lumee Oxygen Platform, which is used for continuous, real-time monitoring of tissue oxygen, and to develop its The post Profusa raises $45m in Series C financing appeared first on Compelo Medical Devices.

Medical Device Firm Anticipates Benefit from Patent Ruling

Source: Streetwise Reports   08/15/2018 This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent.In an Aug. 14 press release, medical device company

Monday 13th August 2018

Renal Anemia| A Drug Pipeline Analysis Report 2018| Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for renal anemia. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat renal

Think you have an iodine allergy? You may want to reconsider.

Let’s begin with a quiz question: Patients may be allergic to: A. oxygen B. carbon C. iodine D. none of the above If you answered anything but “D,” better keep reading. Consider this scenario: If a patient is allergic to penicillin, you would document “penicillin” in the medical records. It would never occur to you […]

TherOx Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryTherOx Inc TherOx is a medical device company that develops and commercializes SuperSaturated Oxygen SSO2 therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherOx's products portfolio comprises downstream systems and downstream cartridge systems. The company's downs...

Innovative New Germ-Killing Light Combats Mold and Mildew in the Shower

The ellumi™ Germ-Killing Recessed Shower Light - Powered by Vital Vio Technology - Safely and Continuously Kills Mold, Mildew, and Bacteria on Surfaces TROY, N.Y. (PRWEB) August 13, 2018 The first-of-its-kind ellumi™ germ-killing Recessed Shower Light – powered by Vital Vio’s proprietary VioSafe® technology which safely, effectively, and continuously kills fungi and bacteria – has ...

New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo multichannel sleep...

Saturday 11th August 2018

Breathe Technologies Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16072018] Prices from USD $250

SummaryBreathe Technologies Inc Breathe Technologies is a home health care service provider that manufactures and develops innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases. The company offers research, development and production of new therapeutics for respiratory system disorders. It offers NIOV that is an artificial breathing system. Breathe ...

Friday 10th August 2018

A1M Pharma’s candidate drug ROSgard™ shows protective effect against acute kidney injury in US study

A1M Pharma AB (publ), 556755-3226 Press release 2018-08-10. A1M Pharma announces that the company's candidate drug ROSgard™ shows a strong protective effect against acute kidney injury (AKI) in a preclinical study conducted in the USA in collaboration with Indiana University. The positive results correlate well with recently reported results from a similar study conducted in Euro...

Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $2000

Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H2 2018, provides an overview of the Coronary Artery Disease CAD Ischemic Heart Disease Cardiovascular pipeline landscape.Coronary artery disease CAD is the most co...

Thursday 9th August 2018

Allina Health Strategic SWOT Analysis Review [Report Updated: 11072018] Prices from USD $125

Allina Health Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by en...

Wednesday 8th August 2018

Adgero Biopharmaceuticals Holdings Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAdgero Biopharmaceuticals Holdings Inc Adgero is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy PDT for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer CMBC and bile duct cancer. Its PDT is a treatment utilizes light sensitive compounds which act as catalyst to produce a form of oxygen that induces local t...

Acute Respiratory Distress Syndrome Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

Acute Respiratory Distress Syndrome Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome Pipeline Review, H2 2018, provides an overview of the Acute Respiratory Distress Syndrome Respiratory pipeline landscape.Acute respiratory distress syndrome ARDS occurs when fluid fills up the air sacs in lungs....

Diffusion Pharmaceuticals Inc DFFN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryDiffusion Pharmaceuticals Inc Diffusion, formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standardofcare therapies. The company offers new and smallmolecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for lifethreatening diseases. Diffusion develops trans sodium crocetinate, a synthetic small molecule that improves the d...

Tuesday 7th August 2018

Inogen Announces Record Second Quarter 2018 Financial Results and Increases 2018 Guidance

- Q2 2018 Sales Revenue up 58.5% Over the Same Period in 2017 - Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month

Few-layer graphdiyne doped with sp-hybridized nitrogen atoms at acetylenic sites for oxygen reduction electrocatalysis

Superoxide Dismutase [CuZn] Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1 Pipeline Review, H1 2018 [Report Updated: 17042018] Prices from USD $3500

Superoxide Dismutase [CuZn] Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1 Pipeline Review, H1 2018SummaryAccording to the recently published report 'Superoxide Dismutase [CuZn] Pipeline Review, H1 2018'; Superoxide Dismutase [CuZn] Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1 pipeline Target constitutes close to 16 mole...

Monday 6th August 2018

New Study Finds Cancer Is Metabolic Disorder Challenging Decades of Genomic Research

Offers New Hope for Breast Cancer Early Diagnosis and Treatment In a study of more than 1,200 patients, published in the Friday, August 3, issue of Oncotarget, an international team of 35 co-investigators from 17 institutions spanning the U.S., Brazil and Europe reported that cancer occurs because cancer cells make and use energy differently from norma...

Sunday 5th August 2018

Ischemia Reperfusion Injury Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $2000

Ischemia Reperfusion Injury Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury Pipeline Review, H2 2018, provides an overview of the Ischemia Reperfusion Injury Cardiovascular pipeline landscape.Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a p...

Saturday 4th August 2018

Teijin Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTeijin Pharma Ltd Teijin Pharma, a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. Teijin Pharma business operations include research and development activities, manufactur...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks